Skip to content
TrialScanner

NCT07757204

An Open-label Long-term Safety Study of Buntanetap in Participants With AD

Phase 2/Phase 3Not yet recruitingANVSLead

Registry record

Lead sponsor
Annovis Bio Inc.
Conditions
Alzheimer's Dementia (AD)
Primary completion
Feb 21, 2030Sponsor estimate
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Sponsor estimate: the sponsor registered this date in advance and can move it. A primary completion date is when the last participant is measured, not when results are announced.

Open NCT07757204 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT07757204: An Open-label Long-term... | TrialScanner